| ［1］ Folkman J. What is the evidence that tumors are angiogenesis-dependent[J]. J Natl Cancer Inst, 1990, 82: 4-6. ［2］ Evelhoch J, LoRusso P, Latif Z, et al. Reproducibility of dynamic contrast-enhanced (DCE-MRI) assessment of tu mo r vascularity, Abstract 399 American Society of Clinical Oncology 37th Annual Meeting[C], San Francisco, CA, 2001.［3］ Chenevert T L, McKeever P E, Ross B D. Monitoring early response of exper ime ntal brain tumor to therapy using diffusion magnetic resonance Imaging[J]. Cli n Cancer Research, 1997,3:1457-1466.［4］ Bihan D L, Tuner R, Mooned C T W, et al. Imaging of diffusion and microcir culation with gradient sensitization: design, strategy, and significance[J]. Journal of Magnetic Resonance Imaging, 1991,1:70-28. ［5］ Su M Y, Jao J C, Nalcioglu O. Measurement of Vascular Volume Fraction and Blood Tissue Permeability Constants with a Pharmacokinetic Model: Studies in Rat Muscle Tumors with Dynamic Gd-DTPA Enhanced MRI[J]. Magnetic Resonance in Medi cine, 1994,32:714-724.［6］ Ng T C, Yang B, Posey J A, et al. Gd-DTPA enhanced arterial phase MRI for Characterizing Tissue Perfusion in Monitoring Anti-angiogenesis Treatment Response of Hepatic Metastases from Colorectal Carcinoma, ISMRM Tenth Scientific Meeting & Exhibition[C]. Abstract 2096, Hawai'i , USA, 2002. ［7］ Toft P S. Modeling tracer kinetics in dynamic GD-DTPA MR imaging[J]. Journal of Magnetic Resonance Imaging, 1997,7:91-101. ［8］ Semelka R C, Ascher S M, Reinhold C. MRI of the Abdomen and pelvis, a text-atlas, chapter 2[M]. New York: Wiley-Liss, Inc, 1997. ISBN 0-471-1 6164-0. |
